1. Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis

   • Edward Mills
   • Kumanan Wilson
   • Keith Gallicano

   Clinical Trials 22 January 2005 Pages: 1 - 7

   

2. Haemodynamic responses to salbutamol and isometric exercise are altered in young adults with mild asthma

   • W Stephen Waring
   • Rachel B. Leigh

   Pharmacodynamics 27 January 2005 Pages: 9 - 14

   

3. CYP2C8 polymorphism frequencies among malaria patients in Zanzibar

   • I. Cavaco
   • J. Strömberg-Nörklit
   • J. P. Gil

   Pharmacogenetics 27 January 2005 Pages: 15 - 18

4. The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians

   • J Rosemary
   • C Adithan
   • R Krishnamoorthy

   Pharmacogenetics 21 January 2005 Pages: 19 - 23

   

5. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients

   • Yukiko Nakajima
   • Yoshiro Saito
   • Jun-ichi Sawada

   Pharmacogenetics 04 February 2005 Pages: 25 - 34

   

6. Effect of multiple-dose erythromycin on everolimus pharmacokinetics

   • J.M. Kovarik
   • D. Beyer
   • R.L. Schmouder

   Pharmacokinetics and Disposition 27 January 2005 Pages: 35 - 38

   

7. Cytochrome P₄₅₀ enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m)

   • Michael Streit
   • Christoph Göggelmann
   • Walter E. Haefeli

   Pharmacokinetics and Disposition 04 February 2005 Pages: 39 - 46

   

8. Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999–2002

   • Gianluca Trifirò
   • Edoardo Spina
   • Giampiero Mazzaglia

   Pharmacoepidemiology and Prescription 22 January 2005 Pages: 47 - 53

   

9. Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors

   • K. Behan
   • C. Cutts
   • Susan E. Tett

   Pharmacoepidemiology and Prescription 27 January 2005 Pages: 55 - 58

   

10. Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients

    • Monica Hermann
    • Anders Åsberg
    • Anders Hartmann

    Short Communication 12 February 2005 Pages: 59 - 62

    

11. A review of randomised clinical trials

    • Werner Frase

    Letter to the Editors 27 January 2005 Pages: 63 - 64

12. Reply to letters EJCP 2004-0271.R1 and EJCP 2004-0275—response requested by Dr D.N. Bateman, Managing Editor

    • E. Ernst
    • K. Schmidt

    Letter to the Editors 27 January 2005 Pages: 65 - 66

13. Reply to EJCP 2004-0275 and 2004-0350

    • Menachem Oberbaum

    Letter to the Editors 27 January 2005 Pages: 67 - 67

14. Self-reported medicine use among adolescents from ethnic minority groups

    • Bjørn E. Holstein
    • Ebba Holme Hansen

    Letter to the Editors 27 January 2005 Pages: 69 - 70

15. Reproductive results associated with misoprostol and other substances utilized for interruption of pregnancy

    • Tatiane da Silva Dal Pizzol
    • Vera Lúcia Tierling
    • Sotero Serrate Mengue

    Letter to the Editors 23 February 2005 Pages: 71 - 72

16. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?

    • D. N. Bateman
    • J. Chick
    • G. Masterton

    Erratum 03 February 2005 Pages: 73 - 73

17. Does the early adopter of drugs exist? A population-based study of general practitioners’ prescribing of new drugs

    • Torben Dybdahl
    • Morten Andersen
    • Ivar Sønbø Kristiansen

    Erratum 04 February 2005 Pages: 75 - 75